GRIMES & Co WEALTH MANAGEMENT LLC Invests $502,000 in Invesco Pharmaceuticals ETF $PJP

GRIMES & Co WEALTH MANAGEMENT LLC bought a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,804 shares of the company’s stock, valued at approximately $502,000. GRIMES & Co WEALTH MANAGEMENT LLC owned approximately 0.13% of Invesco Pharmaceuticals ETF at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PJP. Jones Financial Companies Lllp increased its stake in Invesco Pharmaceuticals ETF by 11.6% in the 1st quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock worth $210,000 after acquiring an additional 252 shares during the last quarter. BNP Paribas Financial Markets bought a new position in shares of Invesco Pharmaceuticals ETF during the 2nd quarter valued at approximately $799,000. Tower Research Capital LLC TRC boosted its position in shares of Invesco Pharmaceuticals ETF by 102.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,680 shares of the company’s stock valued at $374,000 after acquiring an additional 2,374 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Invesco Pharmaceuticals ETF by 214.4% in the third quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after purchasing an additional 8,344 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new position in shares of Invesco Pharmaceuticals ETF in the third quarter valued at $504,000.

Invesco Pharmaceuticals ETF Stock Performance

Shares of PJP opened at $105.56 on Friday. The stock has a market capitalization of $345.18 million, a PE ratio of 15.59 and a beta of 0.46. The company’s fifty day moving average is $104.41 and its 200 day moving average is $104.31. Invesco Pharmaceuticals ETF has a fifty-two week low of $77.69 and a fifty-two week high of $110.81.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.